Model-informed drug development of Mim8 - a next-generation bispecific antibody for treatment of haemophilia A., PMID:40490062
The distinct effect between Amyloid β (1‒40) and Amyloid β (1‒42) on the TRAP-stimulated platelet activation in diabetes mellitus., PMID:40436763
Structural basis of G-quadruplex recognition by a camelid antibody fragment., PMID:40433978
Consistent Killers: Conservation of Thrombin-Like Action on Fibrinogen by Bushmaster (Lachesis Species) Venoms Underpins Broad Antivenom Cross-Reactivities., PMID:40423307
RNAi targeting heparin cofactor II promotes hemostasis in a canine model of acquired hemophilia A., PMID:40413293
Diagnostic value of blood coagulation index in obstetric antiphospholipid syndrome and its subtypes., PMID:40409231
In vitro effects of Mim8 and combined Mim8-bypassing therapy on thrombin generation, thromboelastography and fibrin clot ultrastructure., PMID:40398047
Evaluating the Safety and Efficacy of Concizumab in Hemophilia A/B Patients: A Systematic Review., PMID:40368339
Factor XI and Atrial Fibrillation: A Mismatched Pairing?, PMID:40309219
Recombinant Activated Factor VIIa Combined With Tranexamic Acid Control Haemostasis in Patients With Severe Factor XI Deficiency Undergoing Urological Procedures., PMID:40298276
Bite First, Bleed Later: How Philippine Trimeresurus Pit Viper Venoms Hijack Blood Clotting., PMID:40278683
Case Report: Anti-platelet factor 4 -mediated immunothrombosis in a patient with ANCA vasculitis - a shared mechanism of NETosis., PMID:40276517
HMGB1 derived from macrophages and enteric glial cells contributes to the butyrate-induced colonic hypersensitivity in mice., PMID:40274181
Revolutionizing Treatment Strategies through Inhibition of Tissue Factor Pathway Inhibitor: A Promising Therapeutic Approach for Hemophilia Management., PMID:40200623
Insights from in vitro global assays on possible doses of concomitant hemostatic agents in the presence of NXT007 in hemophilia A., PMID:40199443
Enhancing hemostasis potency in hemophilia with a small interfering ribonucleic acid targeting protein S., PMID:40154791
A Novel Human Anti-FV mAb as a Potential Tool for Diagnostic and Coagulation Inhibitory Approaches., PMID:40141363
Identification and characterization of factor XI autoantibodies in 2 patients with systemic lupus erythematosus: insights into mechanisms of acquired factor XI deficiency., PMID:40129563
Significant attenuation of fully automated thrombin generation in newly diagnosed multiple myeloma patients after induction therapy., PMID:40064842
Clinical Profile of Cerebral Sinus Venous Thrombosis: A Prospective Observational Study in South India., PMID:40058869
Anticoagulant drugs targeting factor XI/XIa and coagulation tests: we urgently need reliable pharmacodynamic data., PMID:40056986
Tissue Factor Pathway-Driven Initial Thrombin Generation is Associated with Hypercoagulability in Obesity., PMID:40049601
Autoantibody Profiles and Prognostic Significance in Severe Fever With Thrombocytopenia Syndrome (SFTS) Patients., PMID:39995275
Guidance-Based Appropriateness of Hemostasis Testing in the Acute Setting., PMID:39970900
Stimulation of endothelin-1 production by autoantibodies present in patients with scleroderma renal crisis., PMID:39956166
Platelet lipidomics indicates enhanced thrombocyte activation in patients with antiphospholipid syndrome in vivo., PMID:39952362
Constructing a logistic regression-based prediction model for subsequent early pregnancy loss in women with pregnancy loss., PMID:39940054
In vitro combined haemostatic efficacy of emicizumab and extended half-life factor VIII compounds., PMID:39937791
The generation and evaluation of TKO/hCD55/hTM/hEPCR gene-modified pigs for clinical organ xenotransplantation., PMID:39902050
2025 Clinical Trials Update on Hemophilia, VWD, and Rare Inherited Bleeding Disorders., PMID:39901862
Coagulation Profile of Convalescent Plasma Donors and Recipients., PMID:39886886
Biomechanical and Functional Features of the Carrier Erythrocytes Prolonging Circulation Time of Biotherapeutic Targeted to Glycophorin A., PMID:39869932
Protection of β2GPI-deficient mice from thrombosis reflects a defect in PAR3-facilitated platelet activation., PMID:39869832
Antibody ligation of HLA class II induces YAP nuclear localization and formation of cytoplasmic YAP condensates in human endothelial cells., PMID:39865973
No correlation between thrombin generation and emicizumab levels: implications for monitoring emicizumab therapy., PMID:39850577
Inflammation and Coagulation in Neurologic and Psychiatric Disorders., PMID:39848256
Structural Conformation and the Binding of Factor VIII R2159C (FVIII-Ise) Mutated in the C1 Domain to Phospholipid., PMID:39837555
Transcriptomic and functional characterization of megakaryocytic-derived platelet-like particles: impaired aggregation and prominent anti-tumor effects., PMID:39812346
Complex Pattern of Platelet Activation/Reactivity After SARS-CoV-2 Infection., PMID:39795908
Understanding the effects of Bothrops erythromelas and Bothrops leucurus venoms on human blood coagulation., PMID:39788325
Brolucizumab and Platelet Activation and Reactivity., PMID:39760267
Gold Nanoprism Enhanced SERS Aptasensor for Simultaneous Detection of Thrombin and VEGF., PMID:39744119
Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot study., PMID:39740931
HINODE study: haemophilia A in infancy and newborns - protocol for a prospective, multicentre, observational study evaluating the coagulation potential and safety of emicizumab prophylaxis., PMID:39725422
Ex vivo evaluation of the effect of plasma-derived factor VIII/von Willebrand factor in patients with severe hemophilia A on emicizumab prophylaxis., PMID:39708197
Deficiency of neutrophil gelatinase-associated lipocalin elicits a hemophilia-like bleeding and clotting disorder in mice., PMID:39693621
Troubleshooting heparin resistance., PMID:39643992
Cross-reactivity of antigenic binding sites of antiphosphatidylserine/prothrombin antibodies in patients with pregnancy loss and epidermal growth factor., PMID:39631139
Non-factor Therapies for Hemophilia: Achievements and Perspectives., PMID:39613145
Recurrent Early Pregnancy Loss and Congenital Thrombophilia: A Prospective Study., PMID:39598015
For research use only. Not for human or drug use.
